Europe IVD Market Hits USD 15.5 Billion By 2024: Grand View Research, Inc.
The Europe IVD market is expected to reach over USD
15.5 billion by 2024 according to a new report by Grand View Research, Inc.
This expected increase in the demand is ascribed to the presence of novel and
promising technologies in clinical laboratories, such as the introduction of
Troponin T test by Roche Diagnostics in May, 2011.
Persistent research and development efforts made to
introduce automation in laboratories that perform analytical testsare projected
to propel the market growth over the forecast period. Clinical laboratory
operations require automated analyzers to cope with the large test
volumes,which enhance the overall operational workflow. It minimizes the need
for dedicated operator training andnegates the risk of human errors. In
addition, the rising demand for portable and handheld IVD devicesis one of the
major factors pushing forward the growth of the market.
The increasing prevalence of chronic diseases, such as
diabetes, cancers, and cardiac dysfunctions and the rising geriatric population
coupled with the rising awareness towards early diagnosis in low-income
countries, such as Bulgaria, Finland, Malta, and Estoniaare the potential
drivers of the Europe IVD market.
Browse full research report on Europe In Vitro
Diagnostics (IVD) Market: http://www.grandviewresearch.com/industry-analysis/europe-in-vitro-diagnostics-ivd-market
Further key findings from the study suggest:
- In
2015, the reagents segment dominated the Europe IVD market due to its
increasing number of applications in the companion diagnostics area and
the introduction of disease specific kits, such as the XpertTB kit
- The
IVD instruments market is anticipated to show lucrative growth due to the
introduction of portable instruments, such as MinION Analyzer by Oxford
Nanopore, and the availability of various platforms to performtarget
sequence analysis, thereby driving the overall demand
- Germany
is one of the largest segments in 2015 with a share of over 19% owing to
the presence of a larger geriatric population base in this region and the
amendment ofthe German lawfor the prevention of hospital-acquired
infections
- UK is
expected to be the fastest growing regionduring the forecast period.The
rising demand for the point-of-care devices coupled with the government
interventions to incorporate innovative, cost-effective solutions in the
healthcare services are expected to drive the market growth during the
forecast period.
- The
hospital-based IVD testing segment held the largest share of over 45% in
2015. The highprocedure volumes in this segment, is one of the major
reasons resulting inthehigh share and;hence, is anticipated to maintain
its market position over the forecast period.
- The
market players of the Europe IVD market include Alere, Inc., bioMerieux,
Inc., Hologic, Inc. (Gen-Probe), Roche Diagnostics, Qiagen N.V., Bio-Rad
Laboratories, Inc., Quidel Corporation, Abbott Laboratories, Inc., Becton,
Dickinson (BD) and Company, Inc., and Siemens Healthcare GmbH
- The
presence of major IVD market players in Europe accelerates the penetration
of the IVD products throughout the European Union. For instance, in
September 2014, Roche Diagnostics launched the CE approved Cobas 6800/8800
systems, which offers IVD-based viral load monitoring withenhanced
flexibility and automation.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Europe IVD market on
the basis of product, technology, application, test location, and region:
Europe In-Vitro Diagnostics (IVD) Market, by Product (USD
Million), 2013 - 2024
- IVD
Instruments
- IVD
Reagents
- Services
- Data
Management
Europe In-Vitro Diagnostics (IVD) Market, by Technique
(USD Million), 2013 - 2024
- Immunochemistry
- Microbiology
- Molecular
diagnostics
- Hematology
- Clinical
Chemistry
- Coagulation
- Other
Clinical Instruments
Europe In-Vitro Diagnostics (IVD) Market, by Application
(USD Million), 2013 - 2024
- Infectious
Diseases
- Diabetes
- Oncology/Cancer
- Cardiology
- Nephrology
- Autoimmune
Diseases
- Drug
Testing
- Others
Europe In-Vitro Diagnostics (IVD) Market, by End-use (USD
Million), 2013 - 2024
- Hospitals
- Laboratory
- Patient
self-testing
- Point-of-care
testing
- Academics
- Others
Europe In-Vitro Diagnostics (IVD) Market, by Country (USD
Million), 2013 - 2024
- Germany
- UK
- France
- Switzerland
- Spain
- Italy
- Belgium
- Austria
- Netherlands
- Sweden
Access press release of this research report by Grand
View Research: http://www.grandviewresearch.com/press-release/europe-in-vitro-diagnostics-ivd-market-analysis
About Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports,
customized research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information:
www.grandviewresearch.com
Comments
Post a Comment